← Back to catalogue
1, 25-(OH)2-Vitamin D3/D2 IDKenhance® IDKmagnetics® DIY LC-MS/MS
EUDAMEDClass B (EU MDR)
Ref YM1042Ref KM1042
Identity
- Trade Name
- 1,25-(OH)2-Vitamin D3/D2 IDKenhance® IDKmagnetics® DIY LC-MS/MS EUDAMED1,25-(OH)2-Vitamin D3/D2 IDKenhance® IDKmagnetics® DIY EUDAMED
- Device Name
- 1,25-(OH)2-Vitamin D3/D2 ImmuTube® LC-MS/MS EUDAMED1,25-(OH)2-Vitamin D3/D2 IDKenhance® IDKmagnetics® DIY LC-MS/MS EUDAMED
- Model / Reference
- YM1042 EUDAMEDKM1042 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 04050598012349 EUDAMED04050598011168 EUDAMED
- Basic UDI-DI
- 4050598CMVITV2 EUDAMEDB-04050598011168 EUDAMED
- Direct Marketing DI
- 04050598012349 EUDAMED
- EMDN Code
- W0102060308 1.25-DIHYDROXYVITAMIN D EUDAMED
Classification
- Device Class
- Class B EUDAMEDClass IVD General EUDAMED
- Market of Registration
- Germany EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Human Tissues
Yes
EUDAMEDEUDAMED
Animal Tissues
No
EUDAMEDEUDAMED
Microbial Substances
No
EUDAMED
Reagent
No
EUDAMEDEUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
Yes
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
New Device
Yes
EUDAMED
1, 25-(OH)2-Vitamin D3/D2 IDKenhance® IDKmagnetics® DIY LC-MS/MS by Immundiagnostik AG — Class B — IVDD, IVDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDD
European Union Active
CE/IVDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDD | 4050598CMVITV2 | Class B | Active |
| EUDAMED | European Union | CE/IVDR | 4050598CMVITV2 | Class B | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Immundiagnostik AG
- EUDAMED SRN
- DE-MF-000020905
Sources (2)
- EUDAMED dd53ce71-6c39-44f3-ad93-b39d8e8c3b89 61 fields · synced Oct 6, 2026
- EUDAMED c6094546-e0ab-4dde-9b92-c4f6c9470587 61 fields · synced Jul 27, 2026